The global prevalence of non-alcoholic fatty liver disease (NAFLD) is 25%. It is considered to be endemic in Europe and a major potential threat to public health. Yet it appears to receive very limited attention. EASL International Liver Foundation aims to place the spotlight on NALFD and take the first important step needed to generate a call to action by developing an understanding of what government and key stakeholders such as medical associations and patient groups are currently doing.

The NASH-CORE study, led by Professor Jeffrey Lazarus, will systematically review the relevant policies European countries have in place to address NAFLD and non-alcoholic steatohepatitis (NASH), the most serious form of NAFLD.

The results of NASH-CORE will be presented in conjunction with the First EASL NAFLD summit, which is being held in Rome, 9-11 November, 2017.

Data Protection and Privacy Policy

EASL International Liver Foundation

We take the protection of your personal data seriously, meaning that we process your personal data with due care and in accordance with applicable data protection laws.


Please note that by clicking the box “I agree”, you explicitly agree to the processing of your personal data for the purposes and pursuant to the terms and conditions mentioned in our Data Protection and Privacy Policy available at here“.


For any question or request, please contact us at EASL International Live Foundation, Rue Daubin 7, 1203 Geneva, Switzerland, telephone 0041 (0)22 552 2497